Masaki Fujisawa

No ORCID on file · 1 paper in corpus · active 2022

Study types

  • rct 1

Condition tags

  • endometriosis 1
  • chronic_pelvic_pain 1
  • endometrioma 1
rct 2022
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.11.013

OBJECTIVE: To evaluate the efficacy and safety of 40-mg relugolix (REL) compared with those of leuprorelin (LEU) in women with endometriosis-associated pain. DESIGN: Phase 3, multicenter, randomized, double-blind, double-dummy, active-cont…